2019年


Desak Nyoman Surya Suameitria Dewi, Ni Made Mertaniasih, Soedarsono, Yuriko Ozeki, Wayan Tunas Artama, Fihiruddin, Mamiko Niki, Yoshitaka Tateishi, Manabu Ato, & Sohkichi Matsumoto

Characteristic profile of antibody responses to PPD, ESAT-6, and CFP-10 of Mycobacterium tuberculosis in pulmonary tuberculosis suspected cases in Surabaya, Indonesia, Brazil J Infect Dis, In press, 2019.

 

Osada-Oka, M., N. Goda, H. Saiga, M. Yamamoto, K. Takeda, Y. Ozeki, T. Yamaguchi, T. Soga, Y. Tateishi, K. Miura, D. Okuzaki, K. Kobayashi, and S. Matsumoto.

Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection. International Immunology In press. 2019

 

Maekura, R., S. Kitada, M. Osada-Oka, Y. Tateishi, Y. Ozeki, T. Fujicawa, M. Miki, O. Jyunnko, M. Mori, and S. Matsumoto.

Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection. Microbiol Immunol 63: 130-138. 2019

 

 

2018年


Yukiko Ohara, Yuriko Ozeki, Yoshitaka Tateishi, Tsukasa Mashima, Fumio Arisaka, Yasuo Tsunaka, Yoshie Fujiwara, Akihito Nishiyama, Yutaka Yoshida, Kengo Kitadokoro, Haruka Kobayashi, Yukihiro Kaneko, Ichiro Nakagawa, Ryoji Maekura, Saburo Yamamoto, Masato Katahira & Sohkichi Matsumoto

「Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis」

PLOS ONE, In press, 2018

 

Anna Savitskaya, Akihito Nishiyama, Takehiro Yamaguchi, Yoshitaka Tateishi, Yuriko Ozeki, Masaaki Nameta, Tomohiro Kon, Shaban A. Kaboso, Naoya Ohara, Olga V. Peryanova, and Sohkichi Matsumoto 

「C-terminal intrinsically disordered region-dependent organization of the mycobacterial genome by a histone-like protein」

Scientific Reports. May29;8(1)8197, 2018

 

Manabu Inoue, Mamiko Niki, Yuriko Ozeki, Sachiyo Nagi, Evans Chadeka, Takehiro Yamaguchi, Mayuko Osada-Oka, Kenji Ono, Tetsuya Oda, Faith Mutungi, Yukihiro Kaneko, Makoto Matsumoto, Satoshi Kaneko, Yoshio Ichinose, Sammy M Njenga, Shinjiro Hamano, and Sohkichi Matsumoto.

「High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages」

Scientific Reports, Apr 30;8(1);6736, 2018

 

 Niki M, Yoshiyama T, Miyamoto Y, Okamura M. Niki M, Oinuma K, Kaneko Y, Matsumoto S, Sasaki Y, Ogata H, Goto H, Kudoh S, and Hoshino Y.

「Longgitudial evaluation of humoral immunity and bacterial and clinical parameters reveals that antige-specific antibodies suppress inflammatory responses in active tuberculosis」

J Immun Res, 4;2018:4928757, 2018

 

尾関 百合子、松本 壮吉. 「結核免疫防御機能」、特集;結核・非結核抗酸菌症(医学書院)、66巻、4号、p643-649、2018

 

松本 壮吉.  「抗酸菌感染症」、バイオフィルム感染症の診断・治療・予防 「臨床と微生物」 45巻、1号、P63-67、2018

 

松本 壮吉. 「マイコバクテリウム属、アクチノマイセスとノカルジア」「シンプル微生物学 改訂第6版」、小熊 恵二、堀田 博、若宮 伸隆 編.南江堂、東京、196-203、2018

 

 

2017年


Enany, S., Y. Yoshida, Y. Tateishi, Y. Ozeki, A. Nishiyama, A. Savitskaya, T. Yamaguchi, Y. Ohara, T. Yamamoto, M. Ato, and S. Matsumoto. 2017. Mycobacterial DNA-binding protein 1 is critical for long term survival of Mycobacterium smegmatis and simultaneously coordinates cellular functions. Scientific reports 7: 6810.

 

Totani, T., Y. Nishiuchi, Y. Tateishi, Y. Yoshida, H. Kitanaka, M. Niki, Y. Kaneko, and S. Matsumoto. 2017. Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression. Scientific reports 7: 41775.

 

Chadeka, E. A., S. Nagi, T. Sunahara, N. B. Cheruiyot, F. Bahati, Y. Ozeki, M. Inoue, M. Osada-Oka, M. Okabe, Y. Hirayama, M. Changoma, K. Adachi, F. Mwende, M. Kikuchi, R. Nakamura, Y. D. J. Kalenda, S. Kaneko, K. Hirayama, M. Shimada, Y. Ichinose, S. M. Njenga, S. Matsumoto, and S. Hamano. 2017. Spatial distribution and risk factors of Schistosoma haematobium and hookworm infections among schoolchildren in Kwale, Kenya. PLoS Negl Trop Dis 11: e0005872.

 

松本 壮吉. 結核の潜在化と発症機構 「結核 改訂版」 光山 正雄、鈴木 克洋 編.医薬ジャーナル社、大阪、134-149、2017

 

 

2016年


Totani, T., Y. Nishiuchi, Y. Tateishi, Y. Yoshida, H. Kitanaka, M. Niki, Y. Kaneko, and S. Matsumoto. 2017. Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression. Sci, Rep 2045-2322 (Electronic).

 

Takahashi, H., M. Haga, T. Sunagawa, T. Saitoh, T. Kitahara, S. Matsumoto, and M. Ohnishi. 2016. Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens. Journal of infection and chemotherapy : 22: 501-504.

 

 

2015年


Niki, M., M. Suzukawa, S. Akashi, H. Nagai, K. Ohta, M. Inoue, M. Niki, Y. Kaneko, K. Morimoto, A. Kurashima, S. Kitada, S. Matsumoto, K. Suzuki, and Y. Hoshino. 2015. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development. J Immunol Res: aa527395.

 

Ozeki, Y., M. Igarashi, M. Doe, A. Tamaru, N. Kinoshita, Y. Ogura, T. Iwamoto, R. Sawa, M. Umekita, S. Enany, Y. Nishiuchi, M. Osada-Oka, T. Hayashi, M. Niki, Y. Tateishi, M. Hatano, and S. Matsumoto. 2015. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren. PLoS One 10: e0141658.

 

Takahashi, H., M. Haga, T. Sunagawa, T. Saitoh, T. Kitahara, S. Matsumoto, and M. Ohnishi. 2016. Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens. Journal of infection and chemotherapy.  In press 

 

松本 壮吉、西山 晃史、尾関 百合子。結核菌の潜伏感染に関わるメカニズムと新しい結核制御技術の可能性。化学療法の領域。31 巻、9号、p93-100、2015

 

松本 壮吉、結核菌の増殖制御や潜在性結核の解析および、結核ワクチンの開発研究。臨床と研究 別刷。92巻、p116、2015

 

立石 善隆、松本 壮吉。結核菌の病原因子。呼吸器内科。29巻、1号、p65-70、2016

 

 

2014年


Nishiuchi, Y., A. Tamaru, Y. Suzuki, S. Kitada, R. Maekura, Y. Tateishi, M. Niki, H. Ogura, and S. Matsumoto. 2014. Direct detection of Mycobacterium avium in environmental water and scale samples by loop-mediated isothermal amplification. J Water Health 12:211-219.

 

Nagi, S., E. A. Chadeka, T. Matsumoto, S. and S. Hamano等 2014. Risk Factors and Spatial Distribution of Schistosoma mansoni Infection among Primary School Children in Mbita District, Western Kenya. PLoS Negl Trop Dis 8:e2991.

 

Fujii, Y., S. Kaneko, S. M. Nzou, S. Matsumoto 等. 2014. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl Trop Dis 8:e3040.

 

Ohtsuka, K., H. Ohnishi, E. Nozaki, J. Pais Ramos, E. Tortoli, S. Yonetani, S. Matsushima, Y. Tateishi, S. Matsumoto, and T. Watanabe. 2014. Whole-Genome Sequence of Mycobacterium kyorinense. Genome Announc 2:e01062-01014.

 

Morimoto, K., T. Ozawa, K. Awazu, N. Ito, N. Honda, S. Matsumoto, and D. Tsuruta. 2014. Photodynamic Therapy Using Systemic Administration of 5-Aminolevulinic Acid and a 410-nm Wavelength Light-Emitting Diode for Methicillin-Resistant Staphylococcus aureus-Infected Ulcers in Mice. PLoS One 9:e105173.

 

松本 壮吉、尾関 百合子。結核ワクチン開発の現状と新しい結核ワクチン開発に向けて。化学療法の領域。30巻、p127-134, 2014.  

 

西内 由紀子、松本 壮吉。抗酸菌の細菌学的特徴と病原性。感染症内科. 2巻、p8-14, 2014

 

松本 壮吉。 結核とその制圧を目指した研究。新潟県医師会報. 第766号. P2-7, 2014

 

西山 晃史、松本 壮吉。病原微生物学、荒川 宣親、神谷 茂、柳 雄介 監修、抗酸菌と放線菌。東京化学同人、東京。120-129、2014

 

 

2013年


Osada-Oka, M., Y. Tateishi, Y. Hirayama, Y. Ozeki, M. Niki, S. Kitada, R. Maekura, K. Tsujimura, Y. Koide, N. Ohara, T. Yamamoto, K. Kobayashi, and S. Matsumoto. 2013. Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis. Microbiol Immunol 57:30-37.

 

Tateishi, Y., A. Tamaru, Y. Ogura, M. Niki, T. Wada, T. Yamamoto, K. Hirata, T. Hayashi, and S. Matsumoto. 2013. Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005. Genome Announc 1.

 

amashita, Y., Y. Hoshino, M. Oka, S. Matsumoto, H. Ariga, H. Nagai, M. Makino, K. Ariyoshi, and Y. Tsunetsugu-Yokota. 2013. Multicolor Flow Cytometric Analyses of CD4(+) T Cell Responses to Mycobacterium tuberculosis-Related Latent Antigens. Jpn J Infect Dis 66:207-215.

 

Taniguchi, K., T. Takii, S. Yamamoto, J. Maeyama, S. Iho, M. Maruyama, N. Iizuka, Y. Ozeki, S. Matsumoto, T. Hasegawa, Y. Miyatake, S. Itoh, and K. Onozaki. 2013. Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG. Immun Ageing 10:25.

 

Fukuda, T., T. Matsumura, M. Ato, M. Hamasaki, Y. Nishiuchi, Y. Murakami, Y. Maeda, T. Yoshimori, S. Matsumoto, K. Kobayashi, T. Kinoshita, and Y. S. Morita. 2013. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis. MBio 4:e00472-00412.

 

松本 壮吉。潜在性結核と結核菌の潜伏感染メカニズム. 医学のあゆみ 246, p470-473, 2013.  

 

松本 壮吉。抗酸菌の休眠現象や薬剤抵抗性に関わる分子メカニズム. Jpn. J. Lepr., 82, p119-122, 2013.  

 

仁木 満美子、松本 壮吉、鉄代謝およびイソニアジド耐性にかかわる結核菌分子の機能と治療法開発の可能性。化学療法の領域、Vol29  2号、p119-124.2013.

 

 

2012年以前


Niki, M., M. Niki, Y. Tateishi, Y. Ozeki, T. Kirikae, A. Lewin, Y. Inoue, M. Matsumoto, J. L. Dahl, H. Ogura, K. Kobayashi, and S. Matsumoto. 2012. A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. J Biol Chem 287:27743-27752.

 

ateishi, Y., S. Kitada, K. Miki, R. Maekura, Y. Ogura, Y. Ozeki, Y. Nishiuchi, M. Niki, T. Hayashi, K. Hirata, K. Kobayashi, and S. Matsumoto. 2012. Whole-Genome Sequence of the Hypervirulent Clinical Strain Mycobacterium intracellulare M.i.198. J Bacteriol 194:6336.

 

Tamaru, A., C. Nakajima, T. Wada, Y. Wang, M. Inoue, R. Kawahara, R. Maekura, Y. Ozeki, H. Ogura, K. Kobayashi, Y. Suzuki, and S. Matsumoto. 2012. Dominant Incidence of Multidrug and Extensively Drug-Resistant Specific Mycobacterium tuberculosis Clones in Osaka Prefecture, Japan. PLoS One 7:e42505.

 

Fujii, J., M. Naito, T. Yutsudo, S. Matsumoto, D. P. Heatherly, T. Yamada, H. Kobayashi, S. Yoshida, and T. Obrig. 2012. Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in Mice. Clin Vaccine Immunol 19:1932-1937.

 

松本 壮吉、結核菌の増殖、長期生存、および静止期以降の薬剤抵抗性獲得の分子メカニズム、Bacterial Adherence & Biofilm、Vol. 26, p21-24,